Motley Fool Australia

Polynovo Ltd (ASX: PNV) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $2.05 billion
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 661.39 million
Earnings per share -0.008
Dividend per share N/A
Year To Date Return -19.07%
Earnings Yield N/A
Franking N/A

Polynovo Ltd (ASX: PNV) Latest News

Young woman in yellow striped top with laptop raises arm in victory

These were the best performing ASX 200 shares in March

More »

asx shares represented by bankers approaching finish line in a race

Brokers think these ASX 200 shares will outperform the market

More »

finger pressing red button on keyboard labelled Buy

Top brokers name 3 ASX shares to buy next week

More »

beaten down shares

Why Galilee Energy, Hansen, Polynovo, & TPG shares are tumbling lower

More »

ASX share

Brokers are bullish on these 4 ASX 200 shares

More »

rising asx share price represented by woman jumping in the air happily

The PolyNovo (ASX:PNV) share price jumps 5% with its latest news

More »

healthcare asx share price rise represented by happy doctor

ASX medical shares report promising half-year results

More »

dog listening through tin can with string attached signifying listening regarding asx share demerger announcements

What’s happening with the PolyNovo (ASX:PNV) share price?

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About Polynovo Ltd (ASX: PNV)

Polynovo Ltd (ASX: PNV) is an Australian-based medical device company that designs, develops and manufactures dermal regeneration solutions.

Its flagship patented NovoSorb biodegradable polymer technology is used to develop innovative medical devices that help surgeons treat patients with traumatic wounds. The company also has a development program covering breast sling, hernia, and orthopaedic applications.

Investors in the Polynovo share price will be happy to know the company is preparing for growth by expanding its manufacturing facility and headquarters in Melbourne, and establishing high quality processes that enable product innovation.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
16 Apr 2021 $3.10 $-0.04 -1.27% 1,352,560 $3.16 $3.16 $3.09
15 Apr 2021 $3.14 $0.01 0.32% 1,294,834 $3.15 $3.17 $3.09
14 Apr 2021 $3.13 $0.18 6.10% 2,502,255 $2.98 $3.16 $2.97
13 Apr 2021 $2.95 $0.06 2.08% 1,654,390 $2.90 $2.98 $2.90
12 Apr 2021 $2.89 $-0.02 -0.69% 844,716 $2.94 $2.95 $2.82
09 Apr 2021 $2.91 $0.00 0.00% 923,651 $2.90 $2.97 $2.89
08 Apr 2021 $2.91 $0.03 1.04% 1,744,890 $2.91 $2.92 $2.86
07 Apr 2021 $2.88 $0.02 0.70% 1,383,214 $2.88 $2.93 $2.86
06 Apr 2021 $2.86 $0.09 3.25% 1,586,951 $2.80 $2.91 $2.79
01 Apr 2021 $2.77 $0.06 2.21% 1,081,263 $2.71 $2.83 $2.71
31 Mar 2021 $2.71 $-0.05 -1.81% 2,932,033 $2.73 $2.78 $2.68
30 Mar 2021 $2.76 $-0.03 -1.08% 2,797,311 $2.81 $2.86 $2.75
29 Mar 2021 $2.79 $-0.06 -2.11% 2,130,112 $2.90 $2.90 $2.79
26 Mar 2021 $2.85 $-0.16 -5.32% 3,124,607 $3.04 $3.06 $2.84
25 Mar 2021 $3.01 $0.14 4.88% 2,995,676 $2.87 $3.05 $2.84
24 Mar 2021 $2.87 $0.03 1.06% 2,477,095 $2.84 $2.92 $2.82
23 Mar 2021 $2.84 $-0.04 -1.39% 1,745,036 $2.91 $2.94 $2.82
22 Mar 2021 $2.88 $0.11 3.97% 2,737,884 $2.79 $2.92 $2.77
19 Mar 2021 $2.77 $0.07 2.59% 1,404,928 $2.69 $2.80 $2.65
18 Mar 2021 $2.70 $-0.02 -0.74% 1,574,517 $2.74 $2.77 $2.65
17 Mar 2021 $2.72 $-0.03 -1.09% 1,218,343 $2.75 $2.76 $2.68
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
26 Mar 2021 Bruce Rathie Sell 200 $571,220
09 Mar 2021 David Williams Buy 100 $234,000
04 Mar 2021 David Williams Buy 300 $721,198
02 Dec 2020 Leon Hoare Sell 100 $345,400
01 Dec 2020 Bruce Rathie Sell 355 $1,194,478
01 Dec 2020 Paul Brennan Sell 200 $678,000
27 Aug 2020 David Williams Buy 500 $1,020,994
27 May 2020 David McQuillan Sell 441 $1,181,554
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr David Williams Non-Executive Director,Non-Executive Chairman Feb 2014
Mr Bruce Rathie Non-Executive Director Feb 2010
Mr Paul Brennan Managing Director Feb 2015
Dr Robyn Elliott Non-Executive Director Oct 2019
Dr David McQuillan Non-Executive Director Aug 2012
Mr Leon Hoare Non-Executive Director Jan 2016
Ms Christine Emmanuel Non-Executive Director May 2020
Mr Jan-Marcel Gielen Chief Financial Officer,Company Secretary Dec 2018
Jan-Marcel Gielen Chief Financial Officer,Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Hsbc Custody Nominees (Australia) Limited 66,551,382 10.07%
J P Morgan Nominees Australia Pty Limited 50,570,980 7.65%
Citicorp Nominees Pty Limited 19,619,513 2.97%
Moggs Creek Pty Ltd 17,400,000 2.63%
Lateral Innovations Pty Ltd 10,924,103 1.65%
National Nominees Limited 9,834,664 1.49%
Merrill Lynch (Australia) Nominees Pty Limited 9,308,685 1.41%
Mr Anthony Shane Kittel & Mrs Michele Therese Kittel 7,922,500 1.20%
BNP Paribas Nominees Pty Ltd 6,625,645 1.00%
BNP Paribas Nominees Pty Ltd (I) 6,186,654 0.94%
Sandhurst Trustees Ltd 5,688,623 0.86%
BNP Paribas Noms Pty Ltd 5,375,513 0.81%
Mr Paul Gerard Brennan 4,185,095 0.63%
Ms Simone Maree Beks 4,185,095 0.63%
Commonwealth Scientific And Industrial Research Organisation 4,081,250 0.62%
Netwealth Investments Limited 3,809,451 0.58%
Mr Paul James Lappin & Ms Siobhan Catherine Lyons 3,254,631 0.49%
Mr Laurent Fossaert 3,214,172 0.49%
Mr David Kenley 3,139,855 0.47%
Dr Marcus James Dermot Wagstaff & Mrs Lara Kate Wagstaff 3,056,377 0.46%
Show more